Spectral AI, Inc. (MDAI)
| Market Cap | 32.15M |
| Revenue (ttm) | 29.58M |
| Net Income (ttm) | -15.32M |
| Shares Out | 25.32M |
| EPS (ttm) | -0.85 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 75,087 |
| Open | 1.280 |
| Previous Close | 1.290 |
| Day's Range | 1.270 - 1.280 |
| 52-Week Range | 0.824 - 3.250 |
| Beta | 0.59 |
| Analysts | Strong Buy |
| Price Target | 4.75 (+274.02%) |
| Earnings Date | May 13, 2025 |
About MDAI
Spectral AI, Inc., an artificial intelligence (AI) company, focuses on predictive medical diagnostics in the United States. Its product, DeepView System, uses proprietary AI algorithms to distinguish between fully damaged, partially damaged, and healthy human tissue characteristics invisible to the naked eye, at the initial time point of wound presentation; and delivers a binary prediction on the wounds capacity to heal or not heal by a specified time point in the future to assist the physician in making a more accurate, timely and informed dec... [Read more]
Financial Performance
In 2024, Spectral AI's revenue was $29.58 million, an increase of 63.83% compared to the previous year's $18.06 million. Losses were -$15.32 million, -26.56% less than in 2023.
Financial StatementsAnalyst Forecast
According to 2 analysts, the average rating for MDAI stock is "Strong Buy." The 12-month stock price forecast is $4.75, which is an increase of 274.02% from the latest price.
News
Burn clinicians present positive findings of the DeepView® System's accuracy at the American Burn Association annual meeting
DALLAS, April 30, 2025 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ: MDAI) (“Spectral AI” or the “Company”), a leading developer of the AI-driven DeepView® System, which uses multi-spectral imaging a...
Spectral AI, Inc. (MDAI) Q4 2024 Earnings Call Transcript
Spectral AI, Inc. (NASDAQ:MDAI) Q4 2024 Earnings Conference Call March 27, 2025 5:00 PM ET Company Participants Sara Prendergast - Assistant General Counsel Michael DiMaio - Chairman Vincent Capone -...
Spectral AI Announces 2024 Fourth Quarter and Full Year Financial Results
2024 Research & Development Revenue of $30 Million
Spectral AI Raises up to $15 Million of Debt Financing and Strengthens Financial Position for U.S. Commercialization
DALLAS, March 24, 2025 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ: MDAI) ("Spectral AI" or the "Company"), a leading developer of the AI-driven DeepView® System, which uses multi-spectral imaging a...
Spectral AI Announces Public Filing of Registration Statement for Proposed Initial Public Offering of Spectral IP
DALLAS, March 20, 2025 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ: MDAI) (“Spectral AI” or the “Company”), developer of the AI-driven DeepView® System, which received Breakthrough Device Designation from...
Spectral AI Announces Successful Results from its Burn Validation Study of the DeepView System
DALLAS, March 17, 2025 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ: MDAI) (“Spectral AI” or the “Company”), developer of the AI-driven DeepView® System, that uses multi-spectral imaging and AI algorithms ...
Spectral AI Completes Three Device Installations in Australia
DALLAS, March 06, 2025 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ: MDAI) (“Spectral AI” or the “Company”), developer of the AI-driven DeepView® System, which received Breakthrough Device Designation from...
CORRECTION: Spectral AI Schedules 2024 Fourth Quarter and Full Year Financial Results and Conference Call
DALLAS, Feb. 28, 2025 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by Spectral AI, Inc. (NASDAQ: MDAI), the reporting date of the financial results for the fourth quar...
Spectral AI Completes Data Analysis for U.S. Burn Pivotal Study
DALLAS, Feb. 07, 2025 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ: MDAI) (“Spectral AI” or the “Company”), developer of the AI-driven DeepView® System, which received Breakthrough Device Designation from ...
Spectral AI Completes Pediatric Enrollment in Emergency Departments for U.S. Burn Pivotal Study
DALLAS, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ: MDAI) (“Spectral AI” or the “Company”), developer of the AI-driven DeepView® System, which received Breakthrough Device Designation from ...
Spectral AI Provides Update to Investors
DALLAS, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ: MDAI) (“Spectral AI” or the “Company”), developer of the AI-driven DeepView® System, which received Breakthrough Device Designation from ...
Spectral AI Provides Instructions for Retail Investors on Exercising Publicly-Traded Warrants
DALLAS, Dec. 31, 2024 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ: MDAI) (“Spectral AI” or the “Company”), developer of the AI-driven DeepView® System, which received Breakthrough Device Designation from ...
Spectral AI Announces Confirmation of Compliance of its Nasdaq Listing Requirements
DALLAS, Dec. 23, 2024 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ: MDAI) (“Spectral AI” or the “Company”), developer of the AI-driven DeepView® System, which received Breakthrough Device Designation from ...
Spectral AI Comments on Compliance with Nasdaq Listing Rule 5550(b)(2)
DALLAS, Dec. 13, 2024 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ: MDAI) (“Spectral AI” or the “Company”), developer of the AI-driven DeepView® System, which received Breakthrough Device Designation from ...
Spectral AI Incorporates Frontline Feedback into Improved Software Release for Enhanced Diagnostic Precision
DALLAS, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on revolutionizing medical diagnostics to enable ...
Spectral AI Completes Truthing of Burn Center Images, Initiates Emergency Department Image Review
DALLAS, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on revolutionizing medical diagnostics to enable ...
Spectral AI Announces Repricing of its Public Warrants
DALLAS, Nov. 26, 2024 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on revolutionizing medical diagnostics to enable ...
Spectral AI Raises Up to $5 Million Financing Strengthening Financial Position for FDA Pathway
DALLAS, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on revolutionizing medical diagnostics to e...
Spectral AI, Inc. (MDAI) Q3 2024 Earnings Conference Call Transcript
Spectral AI, Inc. (NASDAQ:MDAI) Q3 2024 Earnings Conference Call November 6, 2024 5:00 PM ET Company Participants Devin Sullivan - MD of Equity Group Michael DiMaio - Chairman Vincent Capone - CFO Co...
Spectral AI Announces 2024 Third Quarter Financial Results
Revenue Rose to $8.2 Million Company Reaffirms Timeline for Regulatory Submission to U.S. FDA
Spectral AI Announces Plan to Spin Off Spectral IP Subsidiary Focused on Intellectual Property Investments and Monetization
Strategic Spinoff Aims to Unlock IP Value and Sharpen Focus on AI Medical Diagnostics Strategic Spinoff Aims to Unlock IP Value and Sharpen Focus on AI Medical Diagnostics
Spectral AI Schedules 2024 Third Quarter Financial Results and Conference Call
DALLAS, Oct. 23, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more ...
AI in Wound Care Market Industry Research Report 2024-2035 Featuring Key Players - eKare, healthy.io, Kronikare, Intellicure, Perceptive Solutions, Spectral AI, Swift Medical, Wound Pros Among Others
Dublin, Oct. 23, 2024 (GLOBE NEWSWIRE) -- The "AI in Wound Care Market Industry Trends and Global Forecasts to 2035: Distribution by Type of Wound, Type of Acute Wound, Type of Chronic Wound, Type of ...
Spectral AI, Inc. Announces Return of Founder Dr. J. Michael DiMaio as Chairman of the Board of Directors
DALLAS, Oct. 14, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more ...
Spectral AI Completes Proof of Concept for Wound Measurement Technology
Provides Clinicians with Superior Wound Size Measurement Information that Improves Patient Treatment Decisions Provides Clinicians with Superior Wound Size Measurement Information that Improves Patien...